"Parra Dermatología es un Centro Médico dedicado al tratamiento de las enfermedades de la Piel desde 1964"

During the past decade, Parra Dermatología conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Parra Dermatología" #1 collaborator was "Incyte Corporation" with 4 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Parra Dermatología" are "Atopic Dermatitis" (4 trials), "Psoriasis" (2 trials) and "Alopecia Areata" (1 trials). Many other conditions were trialed in "Parra Dermatología" in a lesser frequency.

Most popular intervention types in "Parra Dermatología" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Baricitinib" (4 trials), "Mirikizumab" (2 trials), "LY3375880" (1 trials) and "Secukinumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Parra Dermatología" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Parra Dermatología". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Parra Dermatología, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Parra Dermatología, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".